Skip to main content
11th Annual Pulmonary Embolism Scientific Symposium Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.

Richard Channick, MD

David Geffen School of Medicine at UCLA
David Geffen School of Medicine at UCLA
Los Angeles, CA, United States

Richard Channick, MD, is Professor of Medicine and Saul Brandman Endowed Chair of Pulmonary Arterial Hypertension at David Geffen School of Medicine at UCLA. He serves as Co-Director of the Pulmonary Vascular Disease Program and Director of the Acute and Chronic Thromboembolic Disease at UCLA Medical Center. Dr. Channick received his medical degree from Temple University Medical School, where he was elected to the Alpha Omega Alpha Medical Honor Society. He did his residency and was Chief Resident at the University of Massachusetts Medical Center. He did a pulmonary and critical care fellowship at the University of California, San Diego Medical Center. Dr. Channick was at UCSD for 20 years helping build the pulmonary vascular program there. From 2009-2018 he was at Massachusetts General Hospital, Harvard Medical School where he built a large Pulmonary Vascular Program. He has been at UCLA since September 2018, directing the UCLA Acute and Chronic Thromboembolic Disease Program. Dr. Channick has published over 200 original articles, chapters and reviews focused on all aspects of pulmonary hypertension and pulmonary embolism. He has served on many national and international leadership committees including the American Thoracic Society Pulmonary Circulation Program Committee and the American College of Chest Physicians Pulmonary Vascular Disease Network steering committee, past Chair of the Pulmonary Hypertension Association (PHA) Scientific Leadership Committee and co-founder and past President of the Pulmonary Embolism Response Team (PERT) Consortium. Dr. Channick has served on the steering committees for numerous pivotal clinical trials in pulmonary vascular disease and lectures nationally and internationally.

Disclosure information not submitted.

Presentation(s):